Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 10.256 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; hydrogenated vegetable oil; povidone; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 30.768 mg - capsule, modified release - excipient ingredients: hydrogenated vegetable oil; povidone; magnesium stearate; colloidal anhydrous silica; polyvinyl acetate; sodium lauryl sulfate; titanium dioxide; allura red ac; potable water; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - galantamine hydrobromide, quantity: 20.512 mg - capsule, modified release - excipient ingredients: povidone; magnesium stearate; hydrogenated vegetable oil; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; purified water; shellac; strong ammonia solution; potassium hydroxide; iron oxide black; titanium dioxide; allura red ac; potable water; gelatin; sodium lauryl sulfate; colloidal anhydrous silica; polyvinyl acetate - galantyl is indicated for the treatment of mild to moderately severe dementia of the alzheimer type.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: iron oxide yellow; microcrystalline cellulose; iron oxide red; gelatin; ethylcellulose; hypromellose; magnesium stearate; titanium dioxide; indigo carmine; erythrosine - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; gelatin; magnesium stearate; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; gelatin; microcrystalline cellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - galantamine hydrobromide -